Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inga Zerr

Showing results (211-220 of 358) with videos related to

Pageof 36
Sort By:
Molecular Neurobiology|October 7, 2021
Molecular Profiles of Amyloid-β Proteoforms in Typical and Rapidly Progressive Alzheimer's DiseaseAneeqa Noor, Saima Zafar, Mohsin Shafiq, et al.
Expert Review of Molecular Diagnostics|August 19, 2017
Applications of the real-time quaking-induced conversion assay in diagnosis, prion strain-typing, drug pre-screening and other amyloidopathiesNiccolò Candelise, Matthias Schmitz, Susana Margarida Da Silva Correia, et al.
Molecular Neurodegeneration|February 23, 2021
Prion protein oligomers cause neuronal cytoskeletal damage in rapidly progressive Alzheimer's diseaseMohsin Shafiq, Saima Zafar, Neelam Younas, et al.
Journal of Neurochemistry|April 1, 2025
Alpha-Synuclein Demonstrates Varying Binding Affinities With Different Tau IsoformsAnna-Lisa Fischer, Matthias Schmitz, Tobias Thom, et al.
Molecular Neurobiology|March 25, 2018
Cerebrospinal Fluid Prion Disease Biomarkers in Pre-clinical and Clinical Naturally Occurring ScrapieFranc Llorens, Tomás Barrio, Ângela Correia, et al.
Journal of Neurology|January 9, 2023
Application of real-time quaking-induced conversion in Creutzfeldt-Jakob disease surveillancePeter Hermann, Matthias Schmitz, Maria Cramm, et al.
Communications Biology|March 26, 2021
Distribution of microRNA profiles in pre-clinical and clinical forms of murine and human prion diseaseLesley Cheng, Camelia Quek, Xia Li, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 24, 2016
Electroconvulsive therapy selectively enhances amyloid β 1-42 in the cerebrospinal fluid of patients with major depression: A prospective pilot studyLaura Kranaster, Suna Su Aksay, Jan Malte Bumb, et al.
Frontiers in Neurology|August 5, 2022
Prospective CERAD Neuropsychological Assessment in Patients With Multiple System AtrophyFabian Maass, Peter Hermann, Daniela Varges, et al.
Prion|September 30, 2025
Development of a user guide to support administration of the MRC Prion Disease Rating Scale in research and clinical settings for prion diseasesRobert S Pulido, Chris Marshall, Anne V Smith, et al.
Pageof 36

Showing results (211-220 of 358) with videos related to

Sort By:
Pageof 36
Molecular Neurobiology|October 7, 2021
Molecular Profiles of Amyloid-β Proteoforms in Typical and Rapidly Progressive Alzheimer's DiseaseAneeqa Noor, Saima Zafar, Mohsin Shafiq, et al.
Expert Review of Molecular Diagnostics|August 19, 2017
Applications of the real-time quaking-induced conversion assay in diagnosis, prion strain-typing, drug pre-screening and other amyloidopathiesNiccolò Candelise, Matthias Schmitz, Susana Margarida Da Silva Correia, et al.
Molecular Neurodegeneration|February 23, 2021
Prion protein oligomers cause neuronal cytoskeletal damage in rapidly progressive Alzheimer's diseaseMohsin Shafiq, Saima Zafar, Neelam Younas, et al.
Journal of Neurochemistry|April 1, 2025
Alpha-Synuclein Demonstrates Varying Binding Affinities With Different Tau IsoformsAnna-Lisa Fischer, Matthias Schmitz, Tobias Thom, et al.
Molecular Neurobiology|March 25, 2018
Cerebrospinal Fluid Prion Disease Biomarkers in Pre-clinical and Clinical Naturally Occurring ScrapieFranc Llorens, Tomás Barrio, Ângela Correia, et al.
Journal of Neurology|January 9, 2023
Application of real-time quaking-induced conversion in Creutzfeldt-Jakob disease surveillancePeter Hermann, Matthias Schmitz, Maria Cramm, et al.
Communications Biology|March 26, 2021
Distribution of microRNA profiles in pre-clinical and clinical forms of murine and human prion diseaseLesley Cheng, Camelia Quek, Xia Li, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 24, 2016
Electroconvulsive therapy selectively enhances amyloid β 1-42 in the cerebrospinal fluid of patients with major depression: A prospective pilot studyLaura Kranaster, Suna Su Aksay, Jan Malte Bumb, et al.
Frontiers in Neurology|August 5, 2022
Prospective CERAD Neuropsychological Assessment in Patients With Multiple System AtrophyFabian Maass, Peter Hermann, Daniela Varges, et al.
Prion|September 30, 2025
Development of a user guide to support administration of the MRC Prion Disease Rating Scale in research and clinical settings for prion diseasesRobert S Pulido, Chris Marshall, Anne V Smith, et al.
Pageof 36